Form 4 for RLAY Relay Therapeutics, Inc.
Accepted 2023-09-29 00:00:00 ET · period of report 2023-09-27 · accession 0001209191-23-050869 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-29 | 2023-09-27 | RLAY | Bergstrom Donald A | Pres, R, D | S - Sale | $8.38 | -648 | 238.5K | -0.3% | -$5,430 | |
| 2023-09-29 | 2023-06-30 | RLAY | Bergstrom Donald A | Pres, R, D | A - Grant | $10.68 | +1,228 | 241.8K | +0.5% | +$13.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-27 | S | D | 648 | $8.38 | 238,484 | D | — | — | (F4) Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 2,188 shares of RSUs on September 26, 2023. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs. (F6) Includes 204,085 shares underlying RSUs. (F5) Prior to the reported transaction, the amount of securities beneficially owned by the reporting person was 239,132, with 206,273 shares underlying RSUs. |
| 2 | Common | Common Stock | 2023-06-30 | A | A | 1,228 | $10.68 | 241,815 | D | — | — | (F2) In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on June 30, 2023. (F3) Includes 215,345 shares underlying restricted stock units ("RSUs"). |